The book "Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins" offers a comprehensive analysis of the latest developments in the research and application of antibody-drug conjugates and immunotoxins. It highlights the advances made in the clinical application of these innovative therapies and discusses the mechanisms of their action as well as potential side effects. The authors, Ulf Grawunder and Stefan Barth, provide a deep understanding of the critical factors that must be considered in the development of these drugs, including the identification of suitable target structures and the selection of specific toxic agents. The book is aimed at scientists, biotech companies, and researchers in the fields of immunology, pharmacology, and oncology, and serves as a valuable resource for anyone working at the intersection of research and clinical application.